₹ 0.6 Cr
Volume Transacted
(Nov 22, 2024)
4.8 K
Stocks Traded
(Nov 22, 2024)
Last Updated on: Nov 23, 2024
No data available
The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.
1M
1Y
3Y
5Y
Date | Price (₹) | Day Open (₹) | Day High (₹) | Day Low (₹) |
---|
22 Nov 2024 | 1313.6 | 1286.15 | 1334 | 1286.15 |
21 Nov 2024 | 1284.2 | 1329.95 | 1329.95 | 1278.6 |
19 Nov 2024 | 1306.05 | 1312.1 | 1334.35 | 1290 |
18 Nov 2024 | 1310.5 | 1335.15 | 1355.3 | 1295.05 |
14 Nov 2024 | 1358.75 | 1345.5 | 1382 | 1345.5 |
13 Nov 2024 | 1333.85 | 1403 | 1410 | 1328.6 |
12 Nov 2024 | 1399.15 | 1441.2 | 1448 | 1394.45 |
11 Nov 2024 | 1432.65 | 1429.8 | 1465 | 1399.8 |
08 Nov 2024 | 1396.85 | 1498.95 | 1523.8 | 1380.1 |
07 Nov 2024 | 1437.35 | 1440 | 1456 | 1425 |
Date | Price (₹) |
---|---|
22 Nov 2024 | 1313.6 |
21 Nov 2024 | 1284.2 |
19 Nov 2024 | 1306.05 |
18 Nov 2024 | 1310.5 |
14 Nov 2024 | 1358.75 |
13 Nov 2024 | 1333.85 |
12 Nov 2024 | 1399.15 |
11 Nov 2024 | 1432.65 |
08 Nov 2024 | 1396.85 |
07 Nov 2024 | 1437.35 |
Emcure Pharmaceuticals allots 3.33 lakh equity shares under ESOS
Emcure Pharmaceuticals has allotted 3,33,500 equity shares under ESOS on 22 November 2024....
22 Nov 202417:56
Emcure Pharma Q2 PAT rises 38.2% YoY
In Q2FY25, the drug maker's consolidated revenue from operations stood at Rs 2,002 crore, ...
08 Nov 202412:50
Emcure Pharmaceuticals to hold board meeting
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...
02 Nov 202413:58
Emcure Pharmaceuticals to announce Quarterly Result
Emcure Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 7 N...
31 Oct 202410:43
Emcure signs licensing agreement with Gilead Sciences
Emcure Pharmaceuticals announced the signing of a royalty-free voluntary licensing agreeme...
03 Oct 202410:15
Emcure Pharmaceuticals receives upgrade in credit ratings for bank facilities
Emcure Pharmaceuticals announced that CARE Ratings has upgraded the credit ratings assigne...
13 Aug 202419:01
Unlimited trading at just
Rs. 199*